Nazibur Rahman

Naz Rahman

Eric Ramos

George Marima

Michael Gustitis

- NXGL's direct-to-consumer products division generates approximately **$8 million annually** and the company operates a 16,500 square foot facility in Langhorne, Pennsylvania, utilizing an electron beam accelerator at **18% capacity**.  **[0001468929_2192145_0]** 
- The company has expanded its consumer health and beauty portfolio through acquisitions like **Silly George**, which grew from **$2 million to a $5.5-$6 million annual run rate** since its acquisition in **May 2024**, and strategic partnerships.  **[0001468929_2192145_2]** 
- Key partnerships include a joint venture with **STADA**, which provided **$1 million in non-dilutive capital** and expanded to include 9-11 new products for U.S. release starting in **Q4 2025**.  **[0001468929_2192145_2]** **[0001468929_2192145_4]**  NXGL also partners with **Cintas Corporation** for Silverseal distribution, with initial shipments in **Q4 2024 and Q1 2025**, and anticipates significant revenue from **AbbVie's Resonic** cellulite treatment starting in the **second half of 2026**.  **[0001468929_2192145_2]** **[0001468929_2192145_3]** **[0001468929_2192145_4]** 
- NXGL reported **over 100% revenue growth in Q2 2025**, driven by consumer product sales and contract manufacturing, and is actively developing medical device applications, including an apremilast patch and adhesive solutions for devices like iRhythm's Zio.  **[0001468929_2192145_1]** **[0001468929_2192145_3]** **[0001468929_2192145_4]**

NXGL Reports Strong Q2 2025 Revenue Growth and Details Strategic Partnerships

- NXGL reported **over 100% revenue growth in Q2**, primarily driven by consumer product sales and contract manufacturing.  **[0001468929_2192119_4]** 
- The company's direct-to-consumer products division generates **$8 million annually**, with the recently acquired Silly George beauty brand growing from **$2 million to a $5.5 million to $6 million annual run rate**.  **[0001468929_2192119_0]** **[0001468929_2192119_2]** 
- NXGL has established significant partnerships, including a joint venture with **Stada**, which provided **$1 million in non-dilutive capital** and plans to launch 9-11 additional products, and a distribution agreement with **Cintas Corporation** for SilverSeal.  **[0001468929_2192119_2]** **[0001468929_2192119_3]** 
- Further collaborations include a partnership with **AbbVie** for its Resonic cellulite treatment, with initial orders expected shortly, and **iRhythm**, which is using NXGL's gel as an adhesive for its Zayo device.  **[0001468929_2192119_3]**

NEXGEL (NXGL)